NCT05814718View on ClinicalTrials.gov

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

NANot yet recruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Autologous Stem Cell TransplantationConditioning
Interventions
DRUG

modified BEAM

Mitoxantrone liposome 24 mg/m2，ivgtt，d-7；BCNU 300 mg/m2，ivgtt，d-6； Ara-C 200 mg/m2 q12h，ivgtt，d-5- -2； Vp16 200 mg/m2 ，ivgtt，d-5- -2；

DRUG

BEAM

BCNU 300 mg/m2，-7d； Vp16 200 mg/m2，-6～-3d； Ara-C 100mg/m2 q12h，-6～-3d； Mel 140mg/m2，-2d

Trial Locations (1)

710061

First Affiliated Hospital of Xian Jiaotong University, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT05814718 - Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT | Biotech Hunter | Biotech Hunter